JPWO2022107673A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022107673A5
JPWO2022107673A5 JP2021576325A JP2021576325A JPWO2022107673A5 JP WO2022107673 A5 JPWO2022107673 A5 JP WO2022107673A5 JP 2021576325 A JP2021576325 A JP 2021576325A JP 2021576325 A JP2021576325 A JP 2021576325A JP WO2022107673 A5 JPWO2022107673 A5 JP WO2022107673A5
Authority
JP
Japan
Prior art keywords
packaged beverage
beverage according
content
pig
iron compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021576325A
Other languages
Japanese (ja)
Other versions
JPWO2022107673A1 (en
JP7112040B1 (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/041452 external-priority patent/WO2022107673A1/en
Priority to JP2022008167A priority Critical patent/JP2022081472A/en
Publication of JPWO2022107673A1 publication Critical patent/JPWO2022107673A1/ja
Application granted granted Critical
Publication of JP7112040B1 publication Critical patent/JP7112040B1/en
Publication of JPWO2022107673A5 publication Critical patent/JPWO2022107673A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (10)

豚由来動物プラセンタエキス、及び三価の鉄化合物を含有し、炭水化物含有量が40w/v%以下である容器詰飲料。 A packaged beverage containing a pig-derived animal placenta extract and a trivalent iron compound and having a carbohydrate content of 40 w/v% or less. さらにコラーゲンペプチドを含有する請求項1に記載の容器詰飲料。 The packaged beverage according to claim 1, further comprising collagen peptide. 三価の鉄化合物が、塩化第二鉄、クエン酸鉄、クエン酸鉄アンモニウム及びピロリン酸第二鉄からなる群から選ばれる少なくとも1種である、請求項1又は2に記載の容器詰飲料The packaged beverage according to claim 1 or 2 , wherein the trivalent iron compound is at least one selected from the group consisting of ferric chloride, iron citrate, ferric ammonium citrate and ferric pyrophosphate. 三価の鉄化合物の含有量が、鉄換算で0.0002~0.2w/v%である請求項1~3のいずれかの項に記載の容器詰飲料。 The packaged beverage according to any one of claims 1 to 3, wherein the content of the trivalent iron compound is 0.0002 to 0.2 w/v% in terms of iron. 豚由来動物プラセンタエキスの含有量が、0.001~4w/v%である請求項1~のいずれかの項に記載の容器詰飲料。 The packaged beverage according to any one of claims 1 to 3 , wherein the content of the pig-derived animal placenta extract is 0.001 to 4 w/v%. 豚由来動物プラセンタエキスの含有量が、胎盤換算で0.025~100w/v%である請求項1~5のいずれかの項に記載の容器詰飲料。 The packaged beverage according to any one of claims 1 to 5, wherein the content of the pig-derived animal placenta extract is 0.025 to 100 w/v% in terms of placenta. コラーゲンペプチドの含有量が、0.02~20w/v%である請求項2~6のいずれかに記載の容器詰飲料。 The packaged beverage according to any one of claims 2 to 6, wherein the content of collagen peptide is 0.02 to 20 w/v%. pHが2.5~4.5である請求項1~7のいずれかの項に記載の容器詰飲料。 The packaged beverage according to any one of claims 1 to 7, which has a pH of 2.5 to 4.5. 豚由来動物プラセンタエキスを含有する容器詰飲料において、三価の鉄化合物を添加することを特徴とする沈殿生成抑制方法。 A method for inhibiting precipitation, comprising adding a trivalent iron compound to a packaged beverage containing a porcine-derived animal placenta extract. 豚由来プラセンタエキスを含有する容器詰飲料において、三価の鉄化合物及びコラーゲンペプチドを添加することを特徴とする沈殿生成抑制方法。 A method for inhibiting precipitation, comprising adding a trivalent iron compound and a collagen peptide to a packaged beverage containing a pig-derived placenta extract.
JP2021576325A 2020-11-19 2021-11-11 Beverages containing placenta and iron Active JP7112040B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022008167A JP2022081472A (en) 2020-11-19 2022-01-21 Beverage including placenta and iron

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020192121 2020-11-19
JP2020192121 2020-11-19
PCT/JP2021/041452 WO2022107673A1 (en) 2020-11-19 2021-11-11 Beverage containing placenta and iron

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022008167A Division JP2022081472A (en) 2020-11-19 2022-01-21 Beverage including placenta and iron

Publications (3)

Publication Number Publication Date
JPWO2022107673A1 JPWO2022107673A1 (en) 2022-05-27
JP7112040B1 JP7112040B1 (en) 2022-08-03
JPWO2022107673A5 true JPWO2022107673A5 (en) 2022-11-24

Family

ID=81708827

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021576325A Active JP7112040B1 (en) 2020-11-19 2021-11-11 Beverages containing placenta and iron
JP2022008167A Pending JP2022081472A (en) 2020-11-19 2022-01-21 Beverage including placenta and iron

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022008167A Pending JP2022081472A (en) 2020-11-19 2022-01-21 Beverage including placenta and iron

Country Status (2)

Country Link
JP (2) JP7112040B1 (en)
WO (1) WO2022107673A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11221047A (en) * 1997-10-29 1999-08-17 Masakazu Matsushima Placenta extract-containing liquid agent
JP4715078B2 (en) * 2003-04-16 2011-07-06 大正製薬株式会社 Liquid composition for internal use containing iron compounds
TW200605872A (en) * 2004-05-06 2006-02-16 Taiyokagaku Co Ltd Alcohol-metabolism enhancing composition and ingesta containing the same

Similar Documents

Publication Publication Date Title
AU2022221446B2 (en) Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
ATE336225T1 (en) ALUMINUM-ZIRCONIUM ANTIPERSPIRANT SALTS
MY201148A (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
HUP0302486A2 (en) Antimicrobial and deodorant compositions and process for preparing the same
MX2015017854A (en) Composition comprising glutamic-n,n-diacetate (glda), water and enzyme.
JPWO2022107673A5 (en)
MX2009006684A (en) Compositions for the control of plant pathogens and for use as plant fertilizer.
AR076396A1 (en) COMPOSITION TO SHAPE HAIR
DE602004016486D1 (en) COMPOSITION FOR INHIBITING OR PREVENTING THE REDUCTION OF BONE DENSITY
MX2008011945A (en) Enhanced preservation of processed food.
WO2015075062A3 (en) Method of treating hair
MX2022001630A (en) Fungicide composition.
MX2016002967A (en) Treatment fluids containing a hydrophobically modified chelating agent and methods for use thereof.
BR112018013907A2 (en) sulfur species expulsion agent compositions
ATE398194T1 (en) COMPOSITION AND METHOD FOR TREATING MAGNESIUM ALLOYS
Taylor A challenge to the global liberal order?: The growing Chinese relationship with Africa
WO2020160453A8 (en) Modulators of yap1 expression
WO2021011875A8 (en) Compositions and methods for treating skin conditions
JPWO2020005022A5 (en)
DE60118888D1 (en) PROCESS FOR INCREASING OR BZW. IMPROVING THE SYNTHESIS OF MUCIN
MX2020014028A (en) Pharmaceutical composition containing ilaprazole or salt thereof and preparation method therefor.
Starikova Corinth and Ephyra in Simonides’ Elegy (fr. 15–16 West, Plut. De malign. 872D–E)
RU2019137635A (en) CALCIUM BINDER FOR APPLICATION IN PREVENTION OF CASING
Kumar US-China Trade War: Impact on Sustainable Development in Developing Nations with particular reference to South Asia
CN105166006A (en) Fresh keeping agent for meat products